![]()
41
| 2 | 2008
Klinisk Biokemi i Norden
in Antalya. Task Force is chaired by Mathias Müller
and the members are the Division Chairs and maybe a
few other invited persons. Clinicians should be invol-
ved in the Task Force. The idea is to integrate Scientific
Division’s work on standardization and reference sys-
tems, Education and Management Division’s work on
writing guidelines for implementation and education
of Scientific Divisions work, which are then published
and promoted by Communication and Publication
Division. Finally Committee on Congresses and
Conferences will organize symposia in congresses on
these topics. The first two Integrated IFCC Projects are
Pharmacogenomics and screening for chronic kidney
disease.
The Chair of Task Force on Pediatric Laboratory
Medicine, Klaus Kohse reported that this task force
was formed because children are a special group of
patients. Children are not small adults, which fact is
often forgotten. The main aim of the Task Force is to
coordinate activities worldwide directed towards the
establishment of reference ranges for laboratory test
results in pediatric patients of all age groups. There are
several projects going on in different regions, also in
the Nordic countries, and they all are encouraged to
participate this Task Force. The Task Force also tries
to create a world wide network of scientists working in
laboratories specialized in Pediatric Medicine.
The Chair of Global Campaign of Diabetes Mellitus,
Sverre Sandberg, reported on the activities of this Task
Force. The terms of reference of this Task Force are to
examine the best diagnostic strategy for diagnosing
diabetes mellitus, review and study the current use of
laboratory test, and educate doctors and patients in
interpretation of laboratory tests used in diagnosing
and monitoring of diabetes mellitus, provide qua-
lity specifications for analytes used to diagnose and
monitor diabetes mellitus, give recommendations on
self-monitoring of blood glucose and try to associate
with other groups or persons (including manufactu-
rers) who will co-operate on the work to be done. This
Task Force has worked on the post-analytical quality of
patient results. Questionnaires have been sent to gene-
ral practitioners in different countries and they have
been asked to analyze patient’s status based on given
background information and laboratory test results.
The results of these surveys have been previously
published in several journals.
The fourth day of the General Conference was reser-
ved for the National and Corporate Representatives
totally. They were all divided into five discussion
groups chaired by the Past Presidents of the IFCC. The
topics for the discussion Groups were the following:
The mission and future of Lab Medicine, Educational
(Fortsætter side 42)
